— Know what they know.
Not Investment Advice
Also trades as: GLS (NYSE) · $vol 0M · GLS-WT (NYSE) · $vol 0M

GLSHQ OTC

Gelesis Holdings, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $7334 mcap · 35M float · 0.0006% daily turnover · Short 7% of daily vol

Balance Sheet Trends

Total Assets
$103M -29.4% ▼
Total Liabilities
$116M -20.9% ▼
Shareholders Equity
-$25M +92.4% ▲
Cash & Investments
$7M -73.9% ▼
Total Debt
$62M -6.0% ▼
Net Debt
$55M +44.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022
— Assets —
Cash$492K$28M$7M
Short-Term Investments$0$0$0
Cash & ST Investments$492K$28M$7M
Net Receivables$0$16M$8M
Inventory$0$13M$7M
Other Current Assets$0$4M$0
Total Current Assets$558K$66M$23M
Property, Plant & Equip.$0$59M$61M
Goodwill & Intangibles$0$16M$13M
Long-Term Investments$276M$0$0
Other Non-Current Assets$0$6M$6M
Total Non-Current Assets$276M$80M$80M
Total Assets$277M$146M$103M
— Liabilities —
Accounts Payable$0$10M$4M
Short-Term Debt$0$29M$35M
Deferred Revenue$0$32M$28M
Other Current Liabilities$2M$28M$8M
Total Current Liabilities$2M$69M$78M
Long-Term Debt$0$35M$25M
Other Non-Current Liab.$30M$3M$2M
Total Non-Current Liabilities$40M$395M$37M
Total Liabilities$41M$146M$116M
— Equity —
Common Stock$230M$1K$7K
Retained Earnings-$15M-$266M-$323M
Accumulated OCI$0$219K$104K
Total Stockholders Equity$235M-$330M-$25M
Total Liabilities & Equity$277M-$184M$103M
— Key Metrics —
Total Debt$0$66M$62M
Net Debt-$492K$38M$55M
Total Investments$276M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms